Article
Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells.
Cell reports - 6 Nov 2014
Drawnel Faye M, Boccardo Stefano, Prummer Michael, Delobel Frédéric, Graff Alexandra, Weber Michael, Gérard Régine, Badi Laura, Kam-Thong Tony, Bu Lei, Jiang Xin, Hoflack Jean-Christophe, Kiialainen Anna, Jeworutzki Elena, Aoyama Natsuyo, Carlson Coby, Burcin Mark, Gromo Gianni, Boehringer Markus, Stahlberg Henning, Hall Benjamin J, Magnone Maria Chiara, Kolaja Kyle, Chien Kenneth R, Bailly Jacques, Iacone Roberto
Abstract excerpt
Diabetic cardiomyopathy is a complication of type 2 diabetes, with known contributions of lifestyle and genetics. We develop environmentally and genetically driven in vitro models of the condition using human-induced-pluripotent-stem-cell-derived cardiomyocytes. First, we mimic diabetic clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
